Course of Development and Status quo of Drug Abuse Monitoring in China

doi:10.19803/j.1672-8629.2020.11.06

Abstract

Abstract: Objective To investigate the history of and problems with drug abuse monitoring in China in order to offer new ideas for future work. Methods By reading literature, the course of development of drug abuse monitoring in China was reviewed, achievements summarized, while related difficulties, problems and countermeasures were presented. Results Drug abuse monitoring in China was still in infancy, without a complete legal and regulatory system, clear organizational framework and responsibilities, feasible inter-departmental coordination mechanism, professional talent team or perfect drug abuse monitoring information system. Conclusion It's urgent to establish and improve the related legal system, specify the organization and responsibilities, perfect the mode of monitoring, provide the personnel and expenses needed, establish a long-acting mechanism of communication and cooperation, improve the drug abuse monitoring information system, enhance publicity, and create an atmosphere of social co-governance.

Key words: drug abuse, monitoring, course of development, current situation

CLC Number:

R996.5

BAN bingkun, REN pengyu, WEI jingtu, CAO zijing. Course of Development and Status quo of Drug Abuse Monitoring in China[J]. Chinese Journal of Pharmacovigilance, 2020, 17(11): 777-779.

References

[1] National Medical Products Administration. Annual National Drug Abuse Monitoring Report (China,2016) [EB/OL].(2017-08-11) [2020-01-07]. http://www.nmpa.gov.cn/WS04/CL2196/324182.html.
[2] National Center for ADR Monitoring,China. Compilation of regulatory documents on drug abuse monitoring(药物滥用监测工作法规文件汇编)[C]. Beijing: National Center for ADR Monitoring,China, 2018:1-111.
[3] Yi BL.Investigation and study of Sichuan province drug abuse monitoring present situation[D].Chengdu:University of Eelectronic Sscience and Ttechnology of China(电子科技大学),2015:1-16.
[4] Liu R, Liu YQ, Ding J et al. On modes of surveillance of drug abuse in three northern Chinese provinces[J]. Journal of Lanzhou University(Medical Sciences)(兰州大学学报),2018,44(2):23-27.
[5] The Sstate Ccouncil of China. The notice of the Sstate Ccouncil on the 13th five-year national food safety plan and the 13th five-year national drug safety plan[EB/OL]. (2017-02-21) [2020-01-07].http://www.gov.cn/zhengce/content/2017-02/21/content_5169755.htm.
[6] Wang KH, Wei Y, Xu YM et al. Current status of drug abuse epidemic and intervention research in Cchina[J]. Chinese Journal of Pharmacovigilance(中国药物警戒),2019,16(6):338-341.
[7] National Medical Products Administration. Annual National Drug Abuse Monitoring Report (China, 2014) [EB/OL].(2015-09-08) [2020-01-07]. http://www.nmpa.gov.cn/WS04/CL2168/329325.html.
[8] National Narcotics ControlBan Drugs Commission. Report on the drug situation in Cchina(2014) [R].Beijing: National Ban Drugs Commission,2015.
[9] National Narcotics ControlBan Drugs Commission. Report on the drug situation in Cchina(2015) [R].Beijing: National Ban Drugs Commission,2016.
[10] National Narcotics ControlBan Drugs Commission. Report on the drug situation in Cchina(2016) [R].Beijing: National Ban Drugs Commission,2017.
[11] Cong MC,Bao YP, LV XX et al.The research on the status of national drug abuse surveillance system[J].Chin J Drug Depend(中国药物依赖性杂志), 2013,22(5):386-393.
[12] Yan XS, Hong J, Zhu L.Analysis on the status quo and pProblems of drug abuse monitoring in Anhui Province[J]. Technology Wind(科技风), 2019(5) :212-213.
[13] Cong L, Guo YD, Sui XF.Discussion on the restraining factors influencing the further development of drug abuse monitoring[J]. Chinese Ppharmaceutical Aaffairs(中国药事), 2017,31(5) :463-466.
[14] Chen YF, Huang Y, Dong F et al. Cognitive investigation on drug abuse and drug abuse monitoring among Linyi medical staff. Chinese Journal of Pharmacovigilance(中国药物警戒),2018,15(9):541-544.
[15] Yang SL, Gu YQ, Liu ZX et al. The study on the prevalence of drug abuse and prevention for night clubs[J]. Chin J Drug Depend(中国药物依赖性杂志),2017,26(2):109-114.